Cost Per Median Overall Survival Associated with Abiraterone Acetate and Enzalutamide For Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer in Colombia
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.2587
https://www.valueinhealthjournal.com/article/S1098-3015(17)32921-2/fulltext
Title :
Cost Per Median Overall Survival Associated with Abiraterone Acetate and Enzalutamide For Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer in Colombia
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)32921-2&doi=10.1016/j.jval.2017.08.2587
First page :
A876
Section Title :
SELECTED HEALTH CARE TREATMENT STUDIES -MEDICAL DEVICE/DIAGNOSTICS
Open access? :
No
Section Order :
2379